Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma in Algeria

Malek Benakli, Arezki Tibiche, Nabil Yafour, Kamila Amani, Farah Bouamama, Leila Charef, Samira Bouchama, Khadidja Bouhafs, Amel Baki, Soufi Osmani, Mohamed Brahimi, Rachid Bouhass, Abdessamed Arabi, Mohamed Amine Bekadja, Farih Mehdid, Sabrina Akhrouf, Mounira Baazizi, Nadia Rahmoune, Dina Ait Ouali, Hanane Bouarab, Nacera Ait Amer, Farida Tensaout, Rihab Benouattas, Rachida Belhadj, Amina Talbi, Naima Abdennebi, Farida Harieche, Rose-Marie Hamladji, Redhouane Ahmed Nacer, Fatma Soltani, Mahbouba Ferrari, Mahdia Saidi, Salima Oukid, Cherifa Guezlane, Zohor Bouchetara, Mohand Tayeb Abad, Mohamed Bradai, Lina Kazi Tani, Naima Mesli, Mohamed Cherif Rahali, Mohamed Rafik Abadi, Samir Mnaouar, Khadidja Djouadi, Salahedine Belakehal, Samir Baghdad, Aissa Bachiri, Hadjira Ahmidatou, Soraya Kellouche, Nadia Boudjerra, Nawel Ferroudj, Salim Nekkal, Zohra Kaci, Yamina Bouchakor Moussa, Lynda Louanchi, Meriem Bensadok

Blood (2023) 142 (Supplement 1): 4973.

https://doi.org/10.1182/blood-2023-174045

Published: 2023

Journal Articles

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

Blood (2023) 142 (Supplement 1): 785.

https://doi.org/10.1182/blood-2023-179153

Published: 2023

Journal Articles

Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

Blood (2022) 140 (Supplement 1): 4839–4842.

https://doi.org/10.1182/blood-2022-164619

Published: 2022

Journal Articles

Low Non Relapse Mortality and Good Hematological Response after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective Société Francaise De Greffe De Moelle-Thérapie Cellulaire Observational Study

Blood (2022) 140 (Supplement 1): 7219–7221.

https://doi.org/10.1182/blood-2022-165913

Published: 2022

Journal Articles

International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

Blood (2022) 140 (Supplement 1): 5225–5227.

https://doi.org/10.1182/blood-2022-165010

Published: 2022

Journal Articles

NON Cryopreserved Hematopoietic STEM CELLS to Autograft Patients with Lymphomas: A PAIR Matched Analysis Comparing a Single Center Experience to the Use of Cryopreserved STEM CELLS Reported to the EBMT Registry

Mohamed Amine Bekadja, Ariane Boumendil, Sr., PhD, Didier Blaise, MD, Patrice Chevalier, MD PhD, Karl S Peggs, MD PhD, Gilles Salles, MD PhD, Sebastian Giebel, Sr., Jürgen Finke, Sr., MD PhD, William Arcese, MD PhD, Noel Milpied, Hervé Finel, Sr., MD PhD, Norbert Claude Gorin, Sr., MDPhD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-133900

Published: 2020

Journal Articles

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Mohamed-Amine Bekadja, Mohamed Bradai, Hocine Ait Ali, Selma Hamdi, Nadia Boudjerra, Mahdia Hocine Saidi, Fatiha Grifi, Djamel Saidi, Naima Mesli, Zahia Zouaoui, Nourredine Lakhdari, Nemra Mehalhal, Noureddine Sidimansour, Ryma Tiaiba, Sarah Lakehal, Hossam A Saad, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139569

Published: 2020

Journal Articles

Acceptable Toxicity and Good Hematological and Renal Responses after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective SFGM-TC Observational Study

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-140713

Published: 2020

Journal Articles

Narrowing the Gap for Hematopoietic Cell Transplantation in the East-Mediterranean/African Region: Comparison with Global HSCT Indications and Trends. A Report on Behalf of the East Mediterranean (EMBMT), African Blood and Marrow Transplantation Group (AFBMT) and Worldwide Network for Blood and Marrow Transplantation (WBMT)

Blood (2017) 130 (Supplement 1): 3389.

https://doi.org/10.1182/blood.V130.Suppl_1.3389.3389

Published: 2017

Journal Articles

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Blood (2016) 128 (22): 3450.

https://doi.org/10.1182/blood.V128.22.3450.3450

Published: 2016

Journal Articles

Bortezomib-Based Regimens As Consolidation Therapy after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Single Center Experience from Oran (Algeria)

Souad Talhi, MD, Soufi Osmani, MD, Mohamed Brahimi, MD PhD, Kamila Amani, MD, Hafida Ouldjeriouat, MD, Samira Bouchama, MD, Leila Charef, MD, Mohamed Amine Mazari, MD, Badra Entasoltan, MD, Nabil Yafour, MD, Amina Krim, MD, Rachid Amar Bouhass, MD PhD, Abdessamed Arabi, MD PhD, Mohamed Amine Bekadja

Blood (2016) 128 (22): 5121.

https://doi.org/10.1182/blood.V128.22.5121.5121

Published: 2016

Journal Articles

A Comparison of Efficacy Following Two Different Doses of Granulocyte Colony Stimulating Factor (G-CSF) Alone for Mobilization of Peripheral Blood Stem Cells in 221 Multiple Myeloma Patients

Soufi Osmani, MD, Mohamed Brahimi, MD PhD, Souad Talhi, MD, Kamila Amani, MD, Hafida Ouldjeriouat, MD, Samira Bouchama, MD, Leila Charef, MD, Mohamed Amine Mazari, MD, Badra Entasoltan, MD, Nabil Yafour, MD, Amina Krim, MD, Rachid Amar Bouhass, MDPhD, Abdessamed Arabi, MD PhD, Mohamed Amine Bekadja

Blood (2016) 128 (22): 5732.

https://doi.org/10.1182/blood.V128.22.5732.5732

Published: 2016

Journal Articles

Outcome of Frontline Treatment with Generic Imatinib in Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A First Multicenter Study

Badra Entasoltan, MD, Mohamed Amine Bekadja, Rachid Amar Bouhass, MDPhD, Karima Taibi, Hadj Touhami, Nemra Mehalhal, Mohamed Benlazar, Zahia Zouaoui, Brahim Benzineb, Naima Mesli, Mustapha Talbi, Toufik Yachekour, Aissa Bachiri, Mourad Nachi

Blood (2016) 128 (22): 1899.

https://doi.org/10.1182/blood.V128.22.1899.1899

Published: 2016

Journal Articles

Safety of Subcutaneous Administration of Rituximab during the First-Line Treatment of Patients with Non-Hodgkin Lymphoma: The MabRella Study

Carlos Panizo, Mohamed Amine Bekadja, Balkis Meddeb, Maria Rigoroso Mendoza, Matt Truman, Rodney Smith, Claudia Baratè

Blood (2016) 128 (22): 2971.

https://doi.org/10.1182/blood.V128.22.2971.2971

Published: 2016

Journal Articles

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

Blood (2015) 126 (23): 3034.

https://doi.org/10.1182/blood.V126.23.3034.3034

Published: 2015

NARROW

Autologous Stem Cell Transplantation for Multiple Myeloma in Algeria

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

Low Non Relapse Mortality and Good Hematological Response after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective Société Francaise De Greffe De Moelle-Thérapie Cellulaire Observational Study

International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

NON Cryopreserved Hematopoietic STEM CELLS to Autograft Patients with Lymphomas: A PAIR Matched Analysis Comparing a Single Center Experience to the Use of Cryopreserved STEM CELLS Reported to the EBMT Registry

Epidemiology and Management of Immune Thrombocytopenia in Adult Patients in Algeria: A Non-Interventional, Longitudinal, Nationwide Estimation Study

Acceptable Toxicity and Good Hematological and Renal Responses after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients with Renal Insufficiency at Transplant: A Prospective SFGM-TC Observational Study

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Bortezomib-Based Regimens As Consolidation Therapy after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Single Center Experience from Oran (Algeria)

A Comparison of Efficacy Following Two Different Doses of Granulocyte Colony Stimulating Factor (G-CSF) Alone for Mobilization of Peripheral Blood Stem Cells in 221 Multiple Myeloma Patients

Outcome of Frontline Treatment with Generic Imatinib in Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A First Multicenter Study

Safety of Subcutaneous Administration of Rituximab during the First-Line Treatment of Patients with Non-Hodgkin Lymphoma: The MabRella Study

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only